News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aggredyne Increases IP Portfolio to Four Patents


1/15/2013 9:26:19 AM

HOUSTON--(BUSINESS WIRE)--Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function, has added a fourth patent to its intellectual property portfolio. The new patent, "Systems for Measuring Properties of a Physiologic Fluid Suspension," provides the foundation to expand the AggreGuideTM platform to other coagulation tests, including heparin, Coumadin® (warfarin) and collagen.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES